We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FRSH:NASDAQFreshworks Inc. Analysis

Data as of 2026-09-19 - not real-time

$12.25

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Freshworks Inc. trades at $12.25, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have gained 5.7%. Momentum indicators put RSI at 46.9 (neutral) with MACD reading bearish. The recent range runs from support at $11.70 up to resistance at $13.99.
Valuation screens as undervalued: a P/E of 19.4 sits below the sector average of 33.6. Analyst price targets sit 20.7% above the current price. Revenue is growing at 16.0% on a 20.5% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 48.9%, a beta of 0.60 and a maximum drawdown of 48.8%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 8/10 conviction.

Top Market Events

Beats revenue and profitability expectations, raises full year estimates Total revenues of $237.Freshworks NASDAQ:FRSH delivered its Q2 2026 earnings call on August 4, and the headline number was hard to argue with.Freshworks stock is trading close to its 52-week high after solid second-quarter 2026 results and a

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 10.21
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 19.4 versus sector average of 33.6
  • Trading above the 200-day average of 10.21

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • P/E of 19.4 versus sector average of 33.6
  • Analyst targets imply +20.7% versus the current price
  • Profit margin of 20.5% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth16.00%
Profit Margin20.49%
P/E Ratio19.4
ROE19.70%
ROA1.58%
Debt/Equity3.86
P/B Ratio3.6
Op. Cash Flow$246.7M
Free Cash Flow$260.8M
Industry P/E33.6

Technical Analysis

TrendBullish
RSI46.9
Support$11.70
Resistance$13.99
MA 20$12.85
MA 50$12.00
MA 200$10.21
MACDBearish
VolumeStable
Fear & Greed Index94.98

Valuation

Fair Value$26.31
Target Price$14.79
Upside/Downside20.70%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.60
Volatility48.89%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.